XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
 [1]
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interests
Beginning balance at Dec. 31, 2020 $ 1,579.3 $ (26.2) $ 0.4 $ 780.8 $ (36.9) $ (19.3) $ 808.4 $ 10.7 $ 2.4 $ 6.6
Beginning balance (shares) at Dec. 31, 2020     36,190,000              
Increase (Decrease) in Stockholders' Equity                    
Net income 26.1           25.6     0.5
Other comprehensive income (loss) (19.2)               (19.2)  
Share-based compensation expense 3.4     3.4            
Common stock issued from share-based compensation plans 5.6     5.6            
Common stock issued from share-based compensation plans (shares)     180,000              
Common stock repurchases from share-based compensation plans (3.0)     (3.0)            
Common stock repurchases from share-based compensation plans (in shares)     (20,000.00)              
Other 0.0     0.1           (0.1)
Ending balance at Mar. 31, 2021 1,566.0   $ 0.4 750.0   (19.3) 844.7   (16.8) 7.0
Ending balance (shares) at Mar. 31, 2021     36,350,000              
Beginning balance at Dec. 31, 2021 $ 1,625.2   $ 0.4 779.0   (19.3) 878.2   (21.7) 8.6
Beginning balance (shares) at Dec. 31, 2021 36,548,330   36,550,000              
Increase (Decrease) in Stockholders' Equity                    
Net income $ 10.3           10.2     0.1
Other comprehensive income (loss) (6.0)               (6.0)  
Share-based compensation expense 3.3     3.3            
Common stock issued from share-based compensation plans 1.0     1.0            
Common stock issued from share-based compensation plans (shares)     80,000.00              
Common stock repurchases from share-based compensation plans (3.2)     (3.2)            
Common stock repurchases from share-based compensation plans (in shares)     (20,000.00)              
Earthly Labs Inc. purchase price adjustment (1.2)     (1.2)            
Ending balance at Mar. 31, 2022 $ 1,629.4   $ 0.4 $ 778.9   $ (19.3) $ 888.4   $ (27.7) $ 8.7
Ending balance (shares) at Mar. 31, 2022 36,614,077   36,610,000              
[1] Refer to Note 2, “Significant Accounting Policies” included in our Annual Report on Form 10-K for the year ended December 31, 2021 for discussion regarding the cumulative effect of change in accounting principle.